HOME › DRUGS › EPTINEZUMAB
ACTIVE SUBSTANCE / INN

EPTINEZUMAB

Brand name(s): Vyepti
EMA LISTED
AUTHORISED
Migraine Disorders
ACTIVE SUBSTANCE
Eptinezumab
REGULATORS
EMA
SPONSORS / MAH
H. Lundbeck A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VyeptiH. Lundbeck A/SAuthorised24/01/2022Migraine Disorders

FULL INTELLIGENCE ON EPTINEZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →